دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 4,800,000 تومان- قیمت ویژه : 2,400,000تومان
پکیج دسترسی ۳ ماهه به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 93 ﺭﻭﺯ
- :
قیمت : 1,500,000 تومان- قیمت ویژه : 750,000تومان
Age at Initiation of Lower Gastrointestinal Endoscopy and Colorectal Cancer Risk Among US Women
Wenjie Ma, MD, ScD; Molin Wang, PhD; Kai Wang, MD, PhD; et al.
doi : 10.1001/jamaoncol.2022.0883
July 2022, Vol 8, No. 7, Pages 969-1075
Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast SizeA Randomized Clinical Trial
Danny Vesprini, MD, MSc; Melanie Davidson, PhD; Sandi Bosnic, RTT; et al.
Safety and Efficacy of the mTOR Inhibitor, Vistusertib, Combined With Anastrozole in Patients With Hormone Receptor−Positive Recurrent or Metastatic Endometrial CancerThe VICTORIA Multicenter, Open-label, Phase 1/2 Randomized Clinical Trial
Pierre Heudel, MD, MSc, LLM; Jean-Sébastien Frenel, MD, PhD; Cécile Dalban; et al.
Effect of Denosumab Added to 2 Different nab-Paclitaxel Regimens as Neoadjuvant Therapy in Patients With Primary Breast CancerThe GeparX 2 × 2 Randomized Clinical Trial
Jens-Uwe Blohmer, MD, PhD; Theresa Link, MD; Mattea Reinisch, MD; et al.
Association of 5α-Reductase Inhibitors With Prostate Cancer Mortality
Lars Björnebo, MD, MSc; Tobias Nordström, MD, PhD; Andrea Discacciati, PhD; et al.
Breakthrough SARS-CoV-2 Infections, Hospitalizations, and Mortality in Vaccinated Patients With Cancer in the US Between December 2020 and November 2021
William Wang; David C. Kaelber, MD, MPH, PhD; Rong Xu, PhD; et al.
Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell LymphomaA Randomized Clinical Trial
Xinhua Wang, MD; Lei Zhang, MD; Xiangli Liu, MM; et al.
Evaluation of Safety of Treatment With Anti–Epidermal Growth Factor Receptor Antibody Drug Conjugate MRG003 in Patients With Advanced Solid TumorsA Phase 1 Nonrandomized Clinical Trial
Miao-Zhen Qiu, MD, PhD; Yang Zhang, MD; Ye Guo, MD, PhD; et al.
Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer and Brain MetastasesFinal Results From the Phase 3 ATTAIN Randomized Clinical Trial
Debu Tripathy, MD; Sara M. Tolaney, MD; Andrew D. Seidman, MD; et al.
Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant
Qamar J. Khan, MD; Cory R. Bivona, PharmD; Grace A. Martin, PharmD; et al.
Assessment of Hospitalizations and Emergency Department Visits After Chimeric Antigen Receptor T-Cell Therapy Among Commercially Insured Patients
Kelly M. Kenzik, PhD; P. Connor Johnson, MD; Ravi Bhatia, MD; et al.
Biomarker Testing, Treatment Uptake, and Survival Among Patients With Urothelial Cancer Receiving Gene-Targeted Therapy
Vivek Nimgaonkar, BA, BS; Rebecca A. Hubbard, PhD; Erica L. Carpenter, MBA, PhD; et al.
The Potential of the Gut Microbiome to Reshape the Cancer Therapy ParadigmA Review
Longsha Liu, BA; Khalid Shah, MS, PhD
Colorectal Cancer Screening in the US—Still Putting the Cart Before the Horse?
Ricardo J. Bello, MD, MPH; George J. Chang, MD, MS; Nader N. Massarweh, MD, MPH
Does Circulating Tumor DNA Measure Up to Prostate-Specific Antigen?
Tomi Jun, MD; William K. Oh, MD
A Novel Framework for the Next Generation of Precision Oncology Targets
Christopher T. Chen, MD; James M. Ford, MD
De-escalating Chemotherapy for Advanced Extranodal Natural Killer/T-Cell LymphomaA Step Toward Improved Treatment of a Rare Virus-Associated Cancer
Kathryn Lurain, MD, MPH; Thomas S. Uldrick, MD, MS
Who Will Benefit From Metformin?
Joanne E. Mortimer, MD; Victoria Seewaldt, MD
Colorectal Cancer Incidence Among Adults Younger Than 50 Years—Understanding Findings From Observational Studies of Lower Gastrointestinal Endoscopy
Gregory S. Calip, PharmD, MPH, PhD; Neal J. Meropol, MD; David S. Weinberg, MD, MSc
Prone Whole-Breast Radiotherapy—Better Than Supine?
Dean A. Shumway, MD; Katelyn M. Atkins, MD, PhD
Analysis of Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy Using Pooled Trial Data Matched by Propensity Score
Tanawin Nopsopon, MD; Marie Yung-Chen Wu, MD; Divesh Sardana, MDS, MBA, PhD
Analysis of Association of Radiation Therapy With Risk of Adverse Events in Patients Receiving Immunotherapy Using Pooled Trial Data Matched by Propensity Score—Reply
Chana Weinstock, MD; Anup Amatya, PhD; Julia A. Beaver, MD
